BABA vs HLLY

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

HLLY presents a complex profile where strong defensive valuation metrics clash with poor operational execution. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $3.37 sits comfortably below the Graham Number ($3.69) but significantly above the growth-based Intrinsic Value ($1.12). While the company outperforms its sector in profitability and maintains a strong current ratio, a disastrous earnings track record (0/4 beats in the last year) and negative YoY EPS growth (-63.6%) create significant headwinds. The stock appears undervalued on a book and sales basis, but lacks the fundamental momentum to justify a bullish rating.